TY - JOUR
T1 - Quantification of race/ethnicity representation in Alzheimer’s disease neuroimaging research in the USA
T2 - a systematic review
AU - Lim, Aaron C.
AU - Barnes, Lisa L.
AU - Weissberger, Gali H.
AU - Lamar, Melissa
AU - Nguyen, Annie L.
AU - Fenton, Laura
AU - Herrera, Jennifer
AU - Han, S. Duke
N1 - Publisher Copyright:
© The Author(s) 2023.
PY - 2023/7/25
Y1 - 2023/7/25
N2 - Background: Racial and ethnic minoritized groups are disproportionately at risk for Alzheimer’s Disease (AD), but are not sufficiently recruited in AD neuroimaging research in the United States. This is important as sample composition impacts generalizability of findings, biomarker cutoffs, and treatment effects. No studies have quantified the breadth of race/ethnicity representation in the AD literature. Methods: This review identified median race/ethnicity composition of AD neuroimaging US-based research samples available as free full-text articles on PubMed. Two types of published studies were analyzed: studies that directly report race/ethnicity data (i.e., direct studies), and studies that do not report race/ethnicity but used data from a cohort study/database that does report this information (i.e., indirect studies). Results: Direct studies (n = 719) have median representation of 88.9% white or 87.4% Non-Hispanic white, 7.3% Black/African American, and 3.4% Hispanic/Latino ethnicity, with 0% Asian American, Native Hawaiian/Pacific Islander, and American Indian/Alaska Native, Multiracial, and Other Race participants. Cohort studies/databases (n = 44) from which indirect studies (n = 1745) derived are more diverse, with median representation of 84.2% white, 83.7% Non-Hispanic white, 11.6% Black/African American, 4.7% Hispanic/Latino, and 1.75% Asian American participants. Notably, 94% of indirect studies derive from just 10 cohort studies/databases. Comparisons of two time periods using a median split for publication year, 1994–2017 and 2018–2022, indicate that sample diversity has improved recently, particularly for Black/African American participants (3.39% from 1994–2017 and 8.29% from 2018-2022). Conclusions: There is still underrepresentation of all minoritized groups relative to Census data, especially for Hispanic/Latino and Asian American individuals. The AD neuroimaging literature will benefit from increased representative recruitment of ethnic/racial minorities. More transparent reporting of race/ethnicity data is needed.
AB - Background: Racial and ethnic minoritized groups are disproportionately at risk for Alzheimer’s Disease (AD), but are not sufficiently recruited in AD neuroimaging research in the United States. This is important as sample composition impacts generalizability of findings, biomarker cutoffs, and treatment effects. No studies have quantified the breadth of race/ethnicity representation in the AD literature. Methods: This review identified median race/ethnicity composition of AD neuroimaging US-based research samples available as free full-text articles on PubMed. Two types of published studies were analyzed: studies that directly report race/ethnicity data (i.e., direct studies), and studies that do not report race/ethnicity but used data from a cohort study/database that does report this information (i.e., indirect studies). Results: Direct studies (n = 719) have median representation of 88.9% white or 87.4% Non-Hispanic white, 7.3% Black/African American, and 3.4% Hispanic/Latino ethnicity, with 0% Asian American, Native Hawaiian/Pacific Islander, and American Indian/Alaska Native, Multiracial, and Other Race participants. Cohort studies/databases (n = 44) from which indirect studies (n = 1745) derived are more diverse, with median representation of 84.2% white, 83.7% Non-Hispanic white, 11.6% Black/African American, 4.7% Hispanic/Latino, and 1.75% Asian American participants. Notably, 94% of indirect studies derive from just 10 cohort studies/databases. Comparisons of two time periods using a median split for publication year, 1994–2017 and 2018–2022, indicate that sample diversity has improved recently, particularly for Black/African American participants (3.39% from 1994–2017 and 8.29% from 2018-2022). Conclusions: There is still underrepresentation of all minoritized groups relative to Census data, especially for Hispanic/Latino and Asian American individuals. The AD neuroimaging literature will benefit from increased representative recruitment of ethnic/racial minorities. More transparent reporting of race/ethnicity data is needed.
UR - http://www.scopus.com/inward/record.url?scp=85182186017&partnerID=8YFLogxK
U2 - 10.1038/s43856-023-00333-6
DO - 10.1038/s43856-023-00333-6
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 37491471
AN - SCOPUS:85182186017
SN - 2730-664X
VL - 3
JO - Communications Medicine
JF - Communications Medicine
IS - 1
M1 - 101
ER -